PGEN

4.2101.20%
JB

Jeffrey B. Kindler

Independent Director

Mr. Jeffrey B. Kindler also known as Jeff, J.D., Esq, serves as Independent Director of Lupin Limited since May 06, 2024. He is Director of Praxis Precision Medicines, Inc. from January 8, 2026. He is Advisors & Collaborators of Power Life Sciences, Inc. Mr. Kindler is Member of Business Advisory Board of Excision BioTherapeutics, Inc. from November 03, 2020. Mr. Kindler served as Director of Excision BioTherapeutics Inc. since June 2023. Mr. Kindler is a healthcare executive, investor and advisor who has held leadership positions at companies including Pfizer, McDonald's and General Electric. With experience across multiple industries, Mr. Kindler is a leading expert in pharmaceuticals and other health care sectors, executive management and corporate legal matters including regulation and compliance. He is also a Senior Advisor for Blackstone since June 2020. He serves as an Executive Chairman of EntityRisk, Inc. since April 2023. He serves as Advisory Director since 2021 at Starboard Capital Partners, LLC. Previously he served as Director till 2021 at the firm. Mr. Kindler served as an Operating Partner at Starboard Capital Partners, LLC since December 2018 till 2020. He had been an Independent Director at Terns Pharmaceuticals, Inc. since December 2020 until May 4, 2026. Mr. Kindler serves as a Senior Advisor at The Blackstone Group Inc. since joining on August 4, 2020. He advises across the firm's businesses and portfolio companies, with a focus on Blackstone Tactical Opportunities and Blackstone Growth (BXG). He concentrates on healthcare sector. He has deep management experience and wide-ranging expertise in the healthcare sector. He serves as a senior advisor at Artis Ventures. He served as venture Partner at ARTIS Ventures since January 2020 until February 2024. In this role, he assists with ARTIS’ diligence in the biotech space, counsel portfolio companies and lead the ARTIS Healthcare Pioneers program where he provided strategic counsel on new investment opportunities. He has been Director at PPD, Inc. since March 2012. He served as Chairman of the Board of vTv Therapeutics Inc. since November 25, 2019 until December 23, 2020. He serves as Chief Executive Officer and a member of board of directors since 2013. Mr. Kindler served as an Operating Partner at Starboard Capital Partners, LLC since December 2018 till 2020. Mr. Kindler serves as Chief Executive Officer of Centrexion Therapeutics Corporation since October 2013, Principal and Senior Advisor to Marathon Pharmaceuticals, LLC, since 2012. Mr. Kindler co-founded Centrexion Therapeutics Corporation. Mr. Kindler served as an Executive Chairman of vTv Therapeutics Inc. since July 2015 until November 25, 2019 and had been its Executive Director since April 2015 until November 25, 2019. Mr. Kindler previously served on the board of vTv Therapeutics Inc., a publicly-traded biotechnology company, from July 2015 to December 2020. Mr. Kindler served as a Venture Partner of Lux Capital Management since July 2012 until April 2020. He serves as a Consultant at Efung Capital. He had been an Independent Director of Perrigo Company plc since February 6, 2017 until 2026. He serves as a Director at Vium, Inc., Pharmaceutical Product Development, LLC (PPD), Bio-technology Innovation Organization and Sheridan Healthcare, Inc. Mr. Kindler serves as a Director of Mousera, Inc. He serves as a Member of Advisory Board at Paragon Pharmaceuticals, LLC. Mr. Kindler serves as a Director of Tufts University, the John F. Kennedy Center for the Performing Arts, Business Roundtable, The Manhattan Theatre Club and the Council on Competitiveness and The Business Council. He has been a Director of Partnership to End Addiction at Columbia University since November 21, 2011. Mr. Kindler was a Member of President Obama's Management Advisory Board. Mr. Kindler serves as Member of Advisory Board of Advantia Health LLC and served as its Director. Mr. Kindler serves as a Member of Board of Advisors at Hometeam Care, Inc. and Marathon Pharmaceuticals, LLC. He has extensive business experience and has held leadership positions at some of the world’s most recognized companies. With more than several experience, Mr. Kindler is an expert in pharmaceuticals and other health care sectors, corporate legal matters including regulation, litigation, compliance and crisis management, brand and franchise management, board and corporate governance and executive leadership. He served as a Senior Advisor and Principal of Paragon Pharmaceuticals, LLC. Mr. Kindler is a healthcare executive, investor and advisor who has held leadership positions at some of the world's most recognized companies. He served as the Chairman and Chief Executive Officer of Pfizer Inc. from December 19, 2006 to December 5, 2010 and from July 31, 2006 to December 5, 2010 respectively and Vice Chairman and Executive Vice President from 2002 to 2006. As CEO, he led Pfizer’s merger and acquisition of Wyeth, diversified its product portfolio, improved its research and development pipeline and reshaped the company’s commercial, innovation and leadership models to drive growth and cultural change. Mr. Kindler served as an Executive Vice President of Pfizer Inc. from April 2004 to March 2005 and also served as its Chief Legal officer from January 2002 to December 2010 and Senior Vice President from January 2002 to April 2004. Mr. Kindler joined Pfizer in January 2002 as an Executive Vice President and General Counsel and led its worldwide legal, compliance, communications, government relations, corporate citizenship, policy development and global security groups. He served as the General Counsel of Pfizer Inc. from January 2002 to July 30, 2006. Since retiring from Pfizer in 2010, Mr. Kindler has been active in venture capital and private equity across the healthcare sector. While at Pfizer, he worked with former President Bill Clinton to help medicines to impoverished patients in the developing world through public-private pharmaceutical partnerships. Mr. Kindler also represented the pharmaceutical industry in U.S. government healthcare reform efforts, helping to increase access to affordable medicines while preserving an environment in which pharmaceutical firms can discover and develop innovative treatments. Mr. Kindler also serves as a board member for several civic, charitable and educational institutions. He served as the President of Partner Brands at McDonald's Corporation since 2001. Mr. Kindler served as Chief Legal Officer, Executive Vice President and General Counsel of McDonald's Corporation from 1997 to 2001. Before that, he served as the Vice President of Litigation and Legal Policy at General Electric Company. Mr. Kindler was a Partner at Williams & Connolly, where he practiced civil and criminal litigation. He began his legal career as an Attorney at the Federal Communications Commission. Mr. Kindler was a senior leader at McDonalds Corporation from 1997 to 2001. He served as an

Positions